Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:42:54 EDT Mon 20 Jul 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Z:CLDI - CALIDI BIOTHERAPEUTICS INC - https://ir.calidibio.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CLDI - Z3.10.1131·0.11580.30.1158-0.0044-3.71,493.61161,7600.125  0.125  0.115710.92  0.114315:22:26Jul 0815 min RT 2¢

Recent Trades - Last 10 of 1760
Time ETExPriceChangeVolume
15:22:26Z0.1158-0.0044130
15:22:05Z0.1157-0.0045200
15:21:48Z0.1164-0.0038300
15:21:48Z0.1159-0.0043100
15:21:48Z0.1159-0.0043100
15:20:00Z0.1164-0.0038100
15:19:52Z0.1164-0.0038300
15:19:52Z0.1164-0.0038100
15:19:47Z0.1164-0.0038100
15:19:47Z0.1163-0.00393,700

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-07-08 16:05U:CLDINews ReleaseCalidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
2026-06-24 08:00U:CLDINews ReleaseCalidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
2026-06-23 08:00U:CLDINews ReleaseCalidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
2026-06-16 08:00U:CLDINews ReleaseCalidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study
2026-06-08 08:00U:CLDINews ReleaseCalidi Biotherapeutics Announces Investor Webinar on June 9, 2026
2026-05-26 08:00U:CLDINews ReleaseCalidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting
2026-05-22 18:00U:CLDINews ReleaseCalidi Biotherapeutics Provides Required NYSE American Disclosure
2026-05-14 16:10U:CLDINews ReleaseCalidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights
2026-05-13 08:00U:CLDINews ReleaseCalidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston
2026-04-29 08:00U:CLDINews ReleaseCalidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI
2026-04-21 08:00U:CLDINews ReleaseCalidi Biotherapeutics Presents New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
2026-04-20 08:00U:CLDINews ReleaseCalidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
2026-04-15 08:00U:CLDINews ReleaseCalidi Biotherapeutics Announces Participation in RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
2026-04-14 08:00U:CLDINews ReleaseCalidi Biotherapeutics Announces Speaker Presentation at IOVC Conference in Reykjavik, Iceland on April 28th Highlighting the RedTail Platform's Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
2026-04-07 08:00U:CLDINews ReleaseCalidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform's Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
2026-04-02 08:00U:CLDINews ReleaseCalidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
2026-04-01 08:00U:CLDINews ReleaseCalidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
2026-03-27 16:26U:CLDINews ReleaseCalidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights
2026-03-24 08:00U:CLDINews ReleaseCalidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials
2026-03-12 08:00U:CLDINews ReleaseCalidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing